Boryung, a South Korean pharmaceutical company, has decided to invest $50 million in U.S. commercial space station developer Axiom Space's Series C funding round. The post South Korean pharma invests $50 million in Axiom Space appeared first on SpaceNews.
Boryung, a South Korean pharmaceutical company, has decided to invest $50 million in U.S. commercial space station developer Axiom Space's Series C funding round. The post South Korean pharma invests $50 million in Axiom Space appeared first on SpaceNews.
Share this Article
Recommended